Prognostic markers for colorectal cancer: Expression of P53 and BCL2
✍ Scribed by Hermínia Pereira; Salete Silva; Rui Julião; Palla Garcia; Fátima Perpétua
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 542 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0364-2313
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The products of bcl-2 and p53 genes are involved in the regulation of apoptosis and proliferation and have been associated with prognosis in several malignancies, including colorectal adenocarcinoma. Although 2 European studies have reported a prognostic significance of Bcl-2 expression in colorecta
## Abstract ## Background Cyclooxygenase (COX)‐2 is believed to be an important enzyme related to the pathogenesis of colorectal cancer (CRC). p53 has been reported to be a negative regulator of COX‐2 expression in in vitro studies. The aim of this study was to investigate COX‐2 expression and its
Many studies have tried to discriminate malignant from benign phaeochromocytomas, but until now no widely accepted histological, immunohistochemical, or molecular methods have been available. In this study of 29 malignant and 85 benign phaeochromocytomas from 102 patients, immunohistochemistry was p